Atlanta Consulting Group Advisors, LLC Novartis Ag Transaction History
Atlanta Consulting Group Advisors, LLC
- $403 Billion
- Q3 2024
A detailed history of Atlanta Consulting Group Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Atlanta Consulting Group Advisors, LLC holds 2,754 shares of NVS stock, worth $294,154. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,754Holding current value
$294,154% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.3 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$792 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$791 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$635 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...